Sleep Aids in South Africa
OTC sleep aids remained the smallest category in consumer health in value terms in 2017. Despite the fact that OTC sleep aids are readily available in a range of channels, they are not perceived by consumers to be as effective as prescription medicines. Access to prescription medication is relatively straightforward for middle- and high-income groups which have medical insurance. Consumers without medical insurance and on a limited budget, on the other hand, tend to resort to cheaper alternative...
Euromonitor International's Sleep Aids in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Sleep Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
- SLEEP AIDS IN SOUTH AFRICA
- Euromonitor International
- October 2017
- LIST OF CONTENTS AND TABLES
- Sleep Aids the Smallest Category in Consumer Health As Prescription Medicines Dominate Sales
- Urbanisation and Stressful Lifestyles, Along With Growing Concerns About the Long-term Use of Prescription Drugs, Lead To Consumers Opting for Herbal/traditional Alternatives
- Competitive Landscape
- Aspen Pharmacare Retains Its Leading Position in A Fragmented Category
- Herbal/traditional Brands Subject To More Price Promotions
- Category Data
- Table 1 Sales of Sleep Aids: Value 2012-2017
- Table 2 Sales of Sleep Aids: % Value Growth 2012-2017
- Table 3 NBO Company Shares of Sleep Aids: % Value 2013-2017
- Table 4 LBN Brand Shares of Sleep Aids: % Value 2014-2017
- Table 5 Forecast Sales of Sleep Aids: Value 2017-2022
- Table 6 Forecast Sales of Sleep Aids: % Value Growth 2017-2022
- Executive Summary
- Self-medication and Challenging Economic Climate Impact Growth
- Uncertainty Persists Surrounding Amendments To the Complementary and Alternative Medicines (cams) Act
- Adcock Ingram Maintains Its Leading Position in A Fragmented Industry
- Chemists/pharmacies Remains the Leading Distribution Channel
- Health and Wellness and Self-medication Trends Open Up New Opportunities for Consumer Health Players
- Market Indicators
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
- Table 8 Life Expectancy at Birth 2012-2017
- Market Data
- Table 9 Sales of Consumer Health by Category: Value 2012-2017
- Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
- Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
- Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
- Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
- Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication/self-care and Preventive Medicine
- Summary 1 Research Sources